Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Nutrien

Toyota Motor

The world's a pretty big place. Expand your portfolio's horizons with these international businesses.

3 International Companies Whose Products You May Soon Be Using

The price of CGC stock may soon drop to $30. There isn't much support around the levels where it is currenly trading.

$30 Is Still a Possibility for Canopy Growth Stock

Aurora Cannabis

Cronos Group

CannTrust Holdings

HEXO Corp

It always happens when there is a new kid on the block. The huge interest and momentum buying drives up shares as people hungry to get in pay more than they should for fear of missing out.

Huge Buying Opportunity in Marijuana Stocks as Short Sellers Pounce

While CGC stock has serious challenges impacting it, the headwinds do not directly impugn Canopy's core business potential.
The post Why I Still Believe in Canopy Growth Stock and the Weed Market appeared first on InvestorPlace.

Why I Still Believe in Canopy Growth Stock and the Weed Market

OrganiGram Holdings Inc.

MediPharm Labs, Canopy Growth, and OrganiGram get some love from three of our contributors who cover the marijuana space.

3 Cannabis Stocks Worth Considering for Your Portfolio

Ladenburg Thalmann initiated coverage of the cannabis sector on Wednesday, assigning buy ratings to market leader Canopy Growth Corp.

Ladenburg Thalmann initiates coverage of cannabis sector with buy ratings on Canopy Growth, Aurora

Canopy CFO Mike Lee dishes on growth expectations for fiscal 2020.

Canopy Growth Just Confirmed What We've Long Suspected

CGC stock is suddenly a liability after the industry's problems started to weigh on CGC stock price in recent weeks
The post The Firing of Canopy Growth’s co-CEO Is Only Part of the Case Against CGC Stock appeared first on InvestorPlace.
More From InvestorPlace
		
					
				
					2 Toxic Pot Stocks You Should Avoid				
			
					
				
					9 Retail Stocks Goldman Sachs Says Are Ready to Rip				
			
					
				
					7 Services Stocks to Buy for the Rest of 2019				
			
					
				
					6 Stocks to Buy and 1 to Sell Based on Insider Trading

The Firing of Canopy Growth’s co-CEO Is Only Part of the Case Against CGC Stock

Canopy Growth saw its shares fall 5% last week after CEO Bruce Linton was fired. But Linton's firing is good news for CGC stock going forward.

3 Reasons Linton’s Firing was Good News for Canopy Stock

The buzz is beginning to wear off for the most popular cannabis stocks.

7 Reasons Aurora, Canopy, Cronos, and HEXO Are All At or Near 6-Month Lows

Tilray Brands

Village Farms International

No green flag for cannabis in the U.S., at least at the federal level, anytime soon.

7 Reasons Marijuana Has Virtually No Chance of Being Legalized in the U.S. Before 2021

A new report projects nearly $24 billion in U.S. cannabidiol sales by 2023.

U.S. CBD Sales to Grow an Average of 107% Annually Through 2023

Constellation Brands

Pure-play pot stock or its big partner? Here's which stock looks more attractive over the long run.

Better Marijuana Stock: Canopy Growth vs. Constellation Brands

Find out which cannabis stock is best positioned for this global growth opportunity.

Marijuana Sales to Hit $200 Billion in a Decade, Wall Street Firm Suggests

Hillenbrand

Innovative Industrial Properties

Uncertainty in the cannabis space weighed on marijuana stocks.

Why Innovative Industrial Properties, Hillenbrand, and Canopy Growth Slumped Today

Aphria

GW Pharmaceuticals

Canadian cannabis companies have leapt onto U.S. stock markets, dazzling investors.

Mapping Out Canada's Cannabis Invasion Of The U.S.

Bruce Linton is forced to resign from his CEO and Chairman of the Board positions at Canopy after co-founding the firm six years ago.

Canopy Growth: Life After Bruce Linton Will Be Very Different

Amplify Alternative Harvest ETF

Cannabis stocks are taking a pounding on Friday, and have mostly been under pressure for the past month or so.

A Technical Breakdown In Cannabis Stocks

Hint: It's not a Canadian marijuana grower.

This Is Former Canopy Growth Co-CEO Bruce Linton's Most Logical Landing Spot

Micron Technology

Bed Bath & Beyond

Cigna

Cigna, Bed Bath & Beyond, Micron and Canopy Growth were our top stock trades on Thursday as we go into Friday.

4 Top Stock Trades for Friday (July 12)

Cannabis stocks had a huge showing on Wall Street last fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Get Even Higher on Cannabis Stocks.

One Wall Street firm significantly reduced its price target for Canopy Growth.

Fallout Continues for Canopy Growth Following Co-CEO Linton's Departure

The medical division of Canopy Growth Corp (NYSE: CGC), Spectrum Therapeutics announced Wednesday that it's collaborating with the Canadian Mental Health Association's "Not Myself Today" workplace mental health program.

Spectrum Therapeutics Announces Canadian Mental Health Association Partnership

Marijuana investors might want to keep an eye on these three pot stocks in July.

3 Top Marijuana Stocks to Watch in July

CGC stock continues downward trend that started with disappointing earnings and continued with ouster of founder and Co-CEO Bruce Linton.
The post CGC Stock Reacts to Canopy Co-CEO’s Ouster appeared first on InvestorPlace.

News for Canopy Growth Stock (CGC)